Only 0.01% of drug candidates entering clinical trials reach the market. With Charles River supporting >80% of drugs approved by the FDA over the last three years, improve your odds, leverage our experience, and expedite your time to market.
Our comprehensive portfolio supporting proteins, antibodies, vaccines, and cell and gene therapies includes:
To learn how we can help to get your product to patients faster, visit criver.com/biologics.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.